CVE-2025-62575: NMIS/BioDose V22.02 and previous versions rely on a Microsoft SQL Server database. The SQL user account 'nmdbuser' and…

CVE-2025-62575 · Severity: high · CVSS 8.3 · Published 2025-12-02

NMIS/BioDose V22.02 and previous versions rely on a Microsoft SQL Server database. The SQL user account 'nmdbuser' and other created accounts by default have the sysadmin role. This can lead to remote code execution through the use of certain built-in stored procedures.

Technologies: Mirion Biodose\, Mirion Nmis. Vendors: Mirion.

Quick answers

Is CVE-2025-62575 exploited in the wild?
No. Junglewise Threat Intelligence has no report of CVE-2025-62575 being exploited in the wild.
How severe is CVE-2025-62575?
High severity, with a CVSS score of 8.3, published 2 December 2025.
Which products and versions are affected?
Mirion Biodose\, Mirion Nmis. The advisory does not name versions.
Is there a fix for CVE-2025-62575?
No fixed version is recorded yet. Check the vendor's advisory in the references below. If you run it, Junglewise drafts a mitigation that fits your setup and applies it once you approve, with senior security engineers behind it.
Am I affected by CVE-2025-62575?
Check whether you run Mirion Biodose\ or Mirion Nmis. Junglewise does that check for you around the clock: connect your code, cloud and domains, and it matches new vulnerabilities like this one against what you actually run and tells you when one reaches you.

Affected products

  • Mirion Biodose\
  • Mirion Nmis

This page as Markdown. Free to reuse under CC BY 4.0 with a link back.